Listing 1 - 9 of 9 |
Sort by
|
Choose an application
Within the context of the ISO/IEEE 11073 family of standards for device communication, a normative definition of communication between personal telehealth insulin pump devices and compute engines (e.g., cell phones, personal computers, personal health appliances, set top boxes) in a manner that enables plug-and-play interoperability, is established in this standard. Appropriate portions of existing standards including ISO/IEEE 11073 terminology, information models, application profile standards, and transport standards are leveraged. The use of specific term codes, formats, and behaviors in telehealth environments restricting optionality in base frameworks in favor of interoperability are specified. A common core of communication functionality for personal telehealth insulin pump devices is defined.
Choose an application
Within the context of the ISO/IEEE 11073 family of standards for device communication, a normative definition of communication between personal telehealth insulin pump devices and compute engines (e.g., cell phones, personal computers, personal health appliances, set top boxes), in a manner that enables plug-and-play interoperability, is established in this standard. It leverages appropriate portions of existing standards including ISO/IEEE 11073 terminology, information models, application profile standards, and transport standards. It specifies the use of specific term codes, formats, and behaviors in telehealth environments restricting optionality in base frameworks in favor of interoperability. The standard defines a common core of communication functionality for personal telehealth insulin pump devices.
Insulin pumps. --- Medical instruments and apparatus. --- Medical informatics.
Choose an application
Within the context of the ISO/IEEE 11073 family of standards for device communication, a normative definition of communication between personal telehealth insulin pump devices and compute engines (e.g., cell phones, personal computers, personal health appliances, set top boxes), in a manner that enables plug-and-play interoperability, is established in this standard. It leverages appropriate portions of existing standards including ISO/IEEE 11073 terminology, information models, application profile standards, and transport standards. It specifies the use of specific term codes, formats, and behaviors in telehealth environments restricting optionality in base frameworks in favor of interoperability. The standard defines a common core of communication functionality for personal telehealth insulin pump devices.
Insulin pumps. --- Medical instruments and apparatus. --- Medical informatics.
Choose an application
"This report examines the research evidence on the safety and efficacy of insulin pump therapy, as compared to multiple daily insulin injections, in the treatment of children, adults, and pregnant women diagnosed with type 1 diabetes. The report also analyses the economic impact of introducing the insulin pump therapy in Alberta."
Insulin pumps --- Diabetes --- Insulin Infusion Systems. --- Diabetes Mellitus, Type 1 --- Insulin Infusion Systems --- Insulin --- Therapeutic use. --- Treatment. --- Economic aspects. --- drug therapy. --- economics. --- administration & dosage.
Choose an application
Diabetes is extremely common, with approximately 171 million people affected worldwide. The majority of people with diabetes are cared for in primary care. Primary health care professionals are usually adept at dealing with the lifestyle measures and tablet treatments for diabetes, but generally have limited expertise in the initiation and management of insulin therapy. Insulin therapy has also become more complex, with numerous different forms of insulin and more complex delivery devices available. In a secondary care setting, approximately 10% of in-patients will have diabetes at any one time. People with diabetes stay in hospital longer than people without diabetes, and the condition is often poorly managed during in-patient stays, often leading to clinical errors. Insulin Therapy: A Pocket Guide provides clear and concise information about the safe prescribing of insulin both subcutaneously and intravenously. It covers the different types of insulin, the delivery devices, side effects of insulin and, most importantly, guidance on rational dose adjustment. This book is an invaluable guide for general practitioners and primary care nurses with a special interest in diabetes, as well as junior hospital doctors and specialist medical trainees, advanced nurse practitioners and new diabetes nurse specialists.
Diabetes -- Treatment. --- Diabetes mellitus -- Therapy. --- Insulin infusion systems. --- Insulin pumps. --- Medicine --- Health & Biological Sciences --- Internal Medicine --- Insulin. --- Diabetes. --- Brittle diabetes --- Diabetes mellitus --- IDDM (Disease) --- Insulin-dependent diabetes --- Ketosis prone diabetes --- Type 1 diabetes --- Medicine. --- Internal medicine. --- Endocrinology. --- Medicine & Public Health. --- Internal Medicine. --- Carbohydrate intolerance --- Endocrine glands --- Diabetic acidosis --- Glycosylated hemoglobin --- Diseases --- Hormones --- Hypoglycemic agents --- Pancreas --- Proinsulin --- Secretions --- Internal medicine --- Medicine, Internal --- Endocrinology .
Choose an application
As Editor-in-Chief of the journal Diabetology, I am pleased to announce the Special Issue “Diabetology: Feature Papers 2021” is now published in book format. Diabetology (ISSN 2673-4540) is an international, peer-reviewed scientific open access journal that provides an advanced forum for studies related to epidemiology, etiology, pathophysiology, pathogenesis, management, complications, and prevention of diabetes, including the molecular, biochemical, and physiological aspects of diabetes. In this Special Issue, “Feature Papers”, we aim to publish outstanding contributions in the main fields covered by the journal, which will make a great contribution to the community. This book covers the whole spectrum of diabetology from risk screening, risk markers, pathways of disease in type 1 diabetes and insulin treatment, and management of the disease and comorbidities.
Medicine --- carpal tunnel syndrome --- ultrasound --- power doppler signal --- diabetes --- FINDRISC --- prediabetes --- metabolic syndrome --- young-adults --- N-acetyl-β-d-glucosaminidase (NAG) --- diabetic nephropathy --- chronic kidney disease (CKD) --- meta-analysis --- systematic review --- focus groups --- self-management of type 2 diabetes --- patients’ experiences --- healthcare professionals --- middle-aged population --- type 1 diabetes --- autoimmune diseases --- pancreatic β-cells --- tolerance --- regulatory T cells --- immunotherapy --- insulin --- banting --- best --- MacLeod --- collip --- limited-resource countries (LRC) --- insulin pumps --- blood glucose monitoring --- continuous blood glucose sensors --- COVID-19 --- SARS-CoV-2 --- ACE2 --- TMPRSS2 --- mucormycosis --- COVID-associated mucormycosis (CAM) --- mucins --- Diabetic Keto Acidosis (DKA) --- Metabolic-Stress-Associated Interactome (MSAI) --- olfactory neurovascular niche --- serine proteases --- ferroptosis --- redox-iron stress --- n/a --- patients' experiences
Choose an application
As Editor-in-Chief of the journal Diabetology, I am pleased to announce the Special Issue “Diabetology: Feature Papers 2021” is now published in book format. Diabetology (ISSN 2673-4540) is an international, peer-reviewed scientific open access journal that provides an advanced forum for studies related to epidemiology, etiology, pathophysiology, pathogenesis, management, complications, and prevention of diabetes, including the molecular, biochemical, and physiological aspects of diabetes. In this Special Issue, “Feature Papers”, we aim to publish outstanding contributions in the main fields covered by the journal, which will make a great contribution to the community. This book covers the whole spectrum of diabetology from risk screening, risk markers, pathways of disease in type 1 diabetes and insulin treatment, and management of the disease and comorbidities.
carpal tunnel syndrome --- ultrasound --- power doppler signal --- diabetes --- FINDRISC --- prediabetes --- metabolic syndrome --- young-adults --- N-acetyl-β-d-glucosaminidase (NAG) --- diabetic nephropathy --- chronic kidney disease (CKD) --- meta-analysis --- systematic review --- focus groups --- self-management of type 2 diabetes --- patients’ experiences --- healthcare professionals --- middle-aged population --- type 1 diabetes --- autoimmune diseases --- pancreatic β-cells --- tolerance --- regulatory T cells --- immunotherapy --- insulin --- banting --- best --- MacLeod --- collip --- limited-resource countries (LRC) --- insulin pumps --- blood glucose monitoring --- continuous blood glucose sensors --- COVID-19 --- SARS-CoV-2 --- ACE2 --- TMPRSS2 --- mucormycosis --- COVID-associated mucormycosis (CAM) --- mucins --- Diabetic Keto Acidosis (DKA) --- Metabolic-Stress-Associated Interactome (MSAI) --- olfactory neurovascular niche --- serine proteases --- ferroptosis --- redox-iron stress --- n/a --- patients' experiences
Choose an application
Diabetes is a disease that is now regarded an epidemic in the world and a sign- icant e?ort is directed towards ?nding better ways to manage diabetes. Keeping bloodglucoselevelsasclosetonormalaspossible,leadstoasubstantialdecrease in long term complications of diabetes and can bring signi?cant cost reductions associated with the disease. Traditionally, managing diabetes has been through intermittent monitoring of blood glucose and then administering an appropriate dose of insulin into the blood stream. This method of intermittent monitoring and administration of insulin cannot ensure blood glucose remains at near n- mal levels at all times and therefore, there is considerable interest in managing diabetes on a continuous basis. The development of arti?cial organs/apparatus that regulate human’s blood glucose level has been in progress since 1960. The aim was to measure blood glucose level ex vivo and then injecting an appropriate amount of insulin to the hyperglycaemic patient, thereby correcting the high glucose level. This aim of closing the “loop” is still being challenged by technological barriers even today, and progress are being made constantly both in overcoming the challenges and understanding more about the workings of glucose-regulatory system. The purpose of this book is to introduce the ?eld of closed-loop blood g- cose control, in a simple manner, to the reader. This includes the hardware and software components that make up the control system (see Chapter 2). The hardware components involved the di?erent types of glucose sensor (- vasive, minimally-invasive and non-invasive) and the di?erent types of insulin.
Insulin Infusion Systems --- Blood Glucose --- Diabetes Mellitus --- Drug Therapy, Computer-Assisted --- Monitoring, Physiologic --- Blood sugar monitoring --- Insulin pumps --- Glycémie --- analysis --- drug therapy --- methods --- Technological innovations --- Surveillance --- Innovations --- Drug Therapy --- Methods --- Glucose --- Therapy, Computer-Assisted --- Infusion Pumps --- Glucose Metabolism Disorders --- Drug Delivery Systems --- Diagnostic Techniques and Procedures --- Investigative Techniques --- Endocrine System Diseases --- Therapeutics --- Equipment and Supplies --- Diagnosis --- Metabolic Diseases --- Hexoses --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Diseases --- Artificial Organs --- Decision Making, Computer-Assisted --- Medical Informatics Applications --- Monosaccharides --- Nutritional and Metabolic Diseases --- Surgical Equipment --- Medical Informatics --- Carbohydrates --- Chemicals and Drugs --- Information Science --- Clinical Endocrinology --- Medicine --- Health & Biological Sciences --- Insulin pumps. --- Technological innovations. --- Blood glucose self-monitoring --- Infusion pumps, Insulin --- Insulin infusion pumps --- Pumps, Insulin --- Engineering. --- System theory. --- Control engineering. --- Robotics. --- Mechatronics. --- Biomedical engineering. --- Biomedical Engineering. --- Control, Robotics, Mechatronics. --- Systems Theory, Control. --- Blood sugar --- Patient monitoring --- Drug infusion pumps --- Analysis --- Systems theory. --- Biomedical Engineering and Bioengineering. --- Clinical engineering --- Medical engineering --- Bioengineering --- Biophysics --- Engineering --- Systems, Theory of --- Systems science --- Science --- Philosophy --- Mechanical engineering --- Microelectronics --- Microelectromechanical systems --- Automation --- Machine theory --- Control engineering --- Control equipment --- Control theory --- Engineering instruments --- Programmable controllers --- Insulin Infusion Systems. --- Monitoring, Blood glucose --- Blood glucose --- Blood glucose monitoring
Choose an application
As Editor-in-Chief of the journal Diabetology, I am pleased to announce the Special Issue “Diabetology: Feature Papers 2021” is now published in book format. Diabetology (ISSN 2673-4540) is an international, peer-reviewed scientific open access journal that provides an advanced forum for studies related to epidemiology, etiology, pathophysiology, pathogenesis, management, complications, and prevention of diabetes, including the molecular, biochemical, and physiological aspects of diabetes. In this Special Issue, “Feature Papers”, we aim to publish outstanding contributions in the main fields covered by the journal, which will make a great contribution to the community. This book covers the whole spectrum of diabetology from risk screening, risk markers, pathways of disease in type 1 diabetes and insulin treatment, and management of the disease and comorbidities.
Medicine --- carpal tunnel syndrome --- ultrasound --- power doppler signal --- diabetes --- FINDRISC --- prediabetes --- metabolic syndrome --- young-adults --- N-acetyl-β-d-glucosaminidase (NAG) --- diabetic nephropathy --- chronic kidney disease (CKD) --- meta-analysis --- systematic review --- focus groups --- self-management of type 2 diabetes --- patients' experiences --- healthcare professionals --- middle-aged population --- type 1 diabetes --- autoimmune diseases --- pancreatic β-cells --- tolerance --- regulatory T cells --- immunotherapy --- insulin --- banting --- best --- MacLeod --- collip --- limited-resource countries (LRC) --- insulin pumps --- blood glucose monitoring --- continuous blood glucose sensors --- COVID-19 --- SARS-CoV-2 --- ACE2 --- TMPRSS2 --- mucormycosis --- COVID-associated mucormycosis (CAM) --- mucins --- Diabetic Keto Acidosis (DKA) --- Metabolic-Stress-Associated Interactome (MSAI) --- olfactory neurovascular niche --- serine proteases --- ferroptosis --- redox-iron stress --- carpal tunnel syndrome --- ultrasound --- power doppler signal --- diabetes --- FINDRISC --- prediabetes --- metabolic syndrome --- young-adults --- N-acetyl-β-d-glucosaminidase (NAG) --- diabetic nephropathy --- chronic kidney disease (CKD) --- meta-analysis --- systematic review --- focus groups --- self-management of type 2 diabetes --- patients' experiences --- healthcare professionals --- middle-aged population --- type 1 diabetes --- autoimmune diseases --- pancreatic β-cells --- tolerance --- regulatory T cells --- immunotherapy --- insulin --- banting --- best --- MacLeod --- collip --- limited-resource countries (LRC) --- insulin pumps --- blood glucose monitoring --- continuous blood glucose sensors --- COVID-19 --- SARS-CoV-2 --- ACE2 --- TMPRSS2 --- mucormycosis --- COVID-associated mucormycosis (CAM) --- mucins --- Diabetic Keto Acidosis (DKA) --- Metabolic-Stress-Associated Interactome (MSAI) --- olfactory neurovascular niche --- serine proteases --- ferroptosis --- redox-iron stress
Listing 1 - 9 of 9 |
Sort by
|